MyPass Global is a digital workforce management system founded in Australia in 2013, aimed at improving safety and compliance in heavily-regulated industries. The platform addresses the challenge of workforce compliance tracking by providing a centralized web-based portal that connects workers, employers, sites, and training providers. It allows workers to upload and store their verified qualifications, ensuring they possess the necessary skills for their roles. This functionality not only aids in managing compliance but also assists recruiters in efficiently sourcing both permanent and contract workers while minimizing risks associated with workforce management.
Fleet Space Technologies
Series C in 2023
Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.
BiVACOR, Inc., founded in 2008 and based in Houston, Texas, specializes in the design and manufacture of centrifugal heart pumps aimed at replacing the functions of failing hearts. The company has developed an innovative artificial heart-pumping device that features a compact design with a magnetically levitated rotor situated between opposing pump casings. This advanced rotary blood pump technology is engineered to deliver the necessary cardiac output while minimizing the risks of blood-cell damage and clotting. BiVACOR's team comprises skilled engineers, medical specialists, and business executives who collaborate to enhance this groundbreaking technology. The company also maintains an international office in Brisbane, Australia, fostering a strong network to support its mission.
Vaxxas is a biotechnology company based in Brisbane, Australia, that specializes in developing a needle-free vaccination technology aimed at transforming vaccine delivery. The company's innovative system employs an array of vaccine-coated micro projections that penetrate the outer layers of the skin when applied with a specialized applicator device. This approach allows for direct deposition of vaccines among a dense concentration of immune cells in the skin. Additionally, Vaxxas utilizes proprietary dry-coating technology to minimize or eliminate the need for refrigeration during the storage and transport of vaccines, thereby alleviating the logistical challenges associated with maintaining the cold chain. Founded in 2011, Vaxxas aims to enhance global vaccination efforts through its novel delivery system.
XY Sense
Debt Financing in 2022
XY Sense is a proptech company founded by Alex Birch and Luke Murray, specializing in the development of privacy-preserving sensors and AI-powered analytics to enhance workplace environments. The company's sensors passively collect real-time data on office occupancy and movement, providing accurate workplace utilization analytics with a precision of less than 30 centimeters. This technology allows enterprise property teams to effectively monitor, plan, and optimize their office spaces. XY Sense has gained significant traction in Australia and the Asia Pacific region and has recently expanded its operations into the United States, positioning itself as a leader in workplace optimization solutions.
Drawboard
Debt Financing in 2022
Drawboard Pty Ltd, founded in 2012 and based in Melbourne, Australia, with an additional office in New York, specializes in PDF markup and collaboration solutions. The company's primary offerings include the Drawboard PDF application, which allows users to mark up, discuss, and manage design issues on drawing revisions, and Bullclip, a design communication platform that facilitates collaboration in workspace settings. Drawboard's technology emphasizes real-time document syncing, version control, and layer management, thereby enhancing PDF management workflows for users. By streamlining collaboration for architecture and engineering teams, Drawboard aims to reduce inefficiencies and help professionals focus on their core work without reliance on paper.
Fleet Space Technologies
Debt Financing in 2022
Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.
LegalVision
Debt Financing in 2022
LegalVision is a market disruptor in the commercial legal services industry. Their innovative business model and custom-built technology assist their lawyers to provide a faster, better quality and more cost-effective client experience. LegalVision is a leader in delivering legal services in Australia and has assisted more than 50,000 businesses. The firm was awarded NewLaw Firm of the Year and Innovator of the Year at the Australian Law Awards.
Eucalyptus
Series C in 2022
Eucalyptus, established in 2019 and headquartered in Sydney, Australia, operates as a platform facilitating the creation and management of digital consumer health companies. The company's core business revolves around its telehealth platform, which connects patients with healthcare professionals, facilitates medication delivery, and ensures continuous care. Through this platform, Eucalyptus enables healthcare providers to build and operate digital healthcare businesses efficiently and effectively.
Harmoney
Debt Financing in 2021
Harmoney is an online lending platform that specializes in unsecured personal loans, offering amounts up to $70,000. Established in 2014, it has become Australasia's largest marketplace for personal loans, facilitating over $1.6 billion in loans for more than 50,000 customers in Australia and New Zealand. The platform provides a quick and entirely online application process, allowing individuals to obtain loan quotes without affecting their credit scores. Harmoney offers a diverse range of loan products, including personal, car, wedding, holiday, education, business, and home improvement loans. The company is committed to responsible lending and aims to simplify the borrowing experience through technology and big data. Recognized for its innovative approach, Harmoney has created a purpose-driven culture focused on helping individuals achieve their financial goals.
EatClub
Debt Financing in 2021
EatClub Pty Ltd operates a food application that allows restaurants to manage demand for their tables and enhance profit margins through dynamic pricing. Founded in 2016 and based in East Melbourne, Australia, EatClub was previously known as Dinnerdeal Pty Ltd before rebranding in September 2017. The platform enables restaurants to offer last-minute deals to diners, helping to fill tables during off-peak times. With a partner network of over 1,500 restaurants, including notable names like Sake and Rockpool Dining Group, EatClub serves both Sydney and Melbourne, with plans for further expansion across Australia. The application was designed by restaurateurs and is recognized as a pioneering customer engagement tool in the food service industry.
BiVACOR, Inc., founded in 2008 and based in Houston, Texas, specializes in the design and manufacture of centrifugal heart pumps aimed at replacing the functions of failing hearts. The company has developed an innovative artificial heart-pumping device that features a compact design with a magnetically levitated rotor situated between opposing pump casings. This advanced rotary blood pump technology is engineered to deliver the necessary cardiac output while minimizing the risks of blood-cell damage and clotting. BiVACOR's team comprises skilled engineers, medical specialists, and business executives who collaborate to enhance this groundbreaking technology. The company also maintains an international office in Brisbane, Australia, fostering a strong network to support its mission.
Eucalyptus
Debt Financing in 2021
Eucalyptus, established in 2019 and headquartered in Sydney, Australia, operates as a platform facilitating the creation and management of digital consumer health companies. The company's core business revolves around its telehealth platform, which connects patients with healthcare professionals, facilitates medication delivery, and ensures continuous care. Through this platform, Eucalyptus enables healthcare providers to build and operate digital healthcare businesses efficiently and effectively.
Phocas
Venture Round in 2021
Phocas Limited develops cloud-based business intelligence software tailored for the manufacturing, distribution, and retail sectors. Founded in 2001 and headquartered in Coventry, United Kingdom, with additional offices in Denmark, the United States, Australia, and New Zealand, Phocas serves a diverse clientele across North America, Europe, and Australia. Its software provides users with intuitive dashboards and fast data grids, enabling teams in management, sales, IT, finance, inventory, and purchasing to effectively analyze and utilize company data. Phocas focuses on delivering actionable insights that facilitate strategic decision-making and enhance performance in various industries, including automotive, consumer goods, food and beverage, and healthcare. The platform allows users to drill down from high-level summaries to detailed transactions, transforming data into meaningful information that drives business success.
Phocas
Debt Financing in 2020
Phocas Limited develops cloud-based business intelligence software tailored for the manufacturing, distribution, and retail sectors. Founded in 2001 and headquartered in Coventry, United Kingdom, with additional offices in Denmark, the United States, Australia, and New Zealand, Phocas serves a diverse clientele across North America, Europe, and Australia. Its software provides users with intuitive dashboards and fast data grids, enabling teams in management, sales, IT, finance, inventory, and purchasing to effectively analyze and utilize company data. Phocas focuses on delivering actionable insights that facilitate strategic decision-making and enhance performance in various industries, including automotive, consumer goods, food and beverage, and healthcare. The platform allows users to drill down from high-level summaries to detailed transactions, transforming data into meaningful information that drives business success.
Kira Biotech
Series A in 2019
Kira Biotech, established in 2017 and based in Brisbane, Australia, specializes in the development of innovative immunomodulatory compounds to treat immune system disorders. Its flagship product, KB312, is a first-in-class, selective monoclonal antibody designed to target and deplete activated immune cells, aiming to restore balance and induce immune tolerance. Led by renowned US-based rheumatologist and immunologist Dr. Dan Baker, Kira Biotech is advancing KB312 through preclinical and phase 1 clinical trials, backed by venture capital funding.
Edrolo
Debt Financing in 2019
Edrolo is an Australian edtech startup focused on enhancing education through its online platform. It aims to provide students and schools with access to high-quality educational resources, regardless of their location or school affiliation. The platform offers a variety of online learning materials tailored to secondary and high school curricula, as well as resources for competitive exams and assessments. By connecting learners with inspiring teachers and delivering actionable data for school improvement, Edrolo seeks to foster a more equitable educational landscape and empower students to achieve their best.
Phocas
Venture Round in 2018
Phocas Limited develops cloud-based business intelligence software tailored for the manufacturing, distribution, and retail sectors. Founded in 2001 and headquartered in Coventry, United Kingdom, with additional offices in Denmark, the United States, Australia, and New Zealand, Phocas serves a diverse clientele across North America, Europe, and Australia. Its software provides users with intuitive dashboards and fast data grids, enabling teams in management, sales, IT, finance, inventory, and purchasing to effectively analyze and utilize company data. Phocas focuses on delivering actionable insights that facilitate strategic decision-making and enhance performance in various industries, including automotive, consumer goods, food and beverage, and healthcare. The platform allows users to drill down from high-level summaries to detailed transactions, transforming data into meaningful information that drives business success.
BiVACOR
Venture Round in 2018
BiVACOR, Inc., founded in 2008 and based in Houston, Texas, specializes in the design and manufacture of centrifugal heart pumps aimed at replacing the functions of failing hearts. The company has developed an innovative artificial heart-pumping device that features a compact design with a magnetically levitated rotor situated between opposing pump casings. This advanced rotary blood pump technology is engineered to deliver the necessary cardiac output while minimizing the risks of blood-cell damage and clotting. BiVACOR's team comprises skilled engineers, medical specialists, and business executives who collaborate to enhance this groundbreaking technology. The company also maintains an international office in Brisbane, Australia, fostering a strong network to support its mission.
Prota Therapeutics
Series A in 2017
Prota Therapeutics is an Australian biotechnology company founded in 2016, focused on developing and commercializing innovative probiotic allergen oral immunotherapy treatments, particularly for peanut allergies in children. The company holds an exclusive license for a patented probiotic food immunotherapy technology created at the Murdoch Children's Research Institute. Prota has secured AUD $15 million in Series A funding, which includes contributions from OneVentures and the Australian Commonwealth Government's Biomedical Translation Fund. This financial backing has facilitated the advancement of their clinical program, the development of scalable cGMP manufacturing processes, and initial discussions with regulatory agencies. Prota plans to conduct a large-scale pivotal Phase 3 efficacy and safety study for its PRT100 treatment, aiming to provide effective immunotherapy solutions for individuals suffering from peanut allergies and to improve their quality of life.
Smart Sparrow
Series C in 2017
Smart Sparrow operates an innovative e-learning platform that allows educators and organizations to create interactive and adaptive courseware across various subjects, such as digital literacy, computer science, engineering, finance, and soft skills. Founded in December 2010 by Ariel Shoham, Dror Ben-Haim, Shaowei Ho, and Zack Belinson, the company is headquartered in Surry Hills, Australia, with an additional office in San Francisco, California. The platform features a user-friendly, drag-and-drop authoring tool accessible through any web browser, enabling educators to build customized courses, define personalized learning paths for students, and collaborate in real-time. Additionally, Smart Sparrow provides pre-made templates to streamline the course creation process, serving a diverse range of institutions both locally and internationally.
Find-Me Technologies Pty
Venture Round in 2015
Find-Me Technologies Pty Ltd is an Australian company that specializes in developing and manufacturing personal mobile emergency alert systems, primarily in the form of watches. The company offers two main products: the Carers Watch and personal safety watches. The Carers Watch is designed to assist caregivers in monitoring individuals with conditions such as dementia, Alzheimer’s, and other health concerns, featuring capabilities like GPS tracking, two-way voice communication, a panic alert button, and a fall sensor. This watch is lightweight and versatile, allowing it to be worn comfortably like a regular watch or as a brooch or pendant. The personal safety watches cater to a broader audience, including emergency services personnel, security staff, and individuals in high-risk professions, enabling users to send alerts to monitoring centers in dangerous situations. Find-Me Technologies distributes its products in Australia, New Zealand, the United Kingdom, and Kazakhstan. Established in 2010 and based in Loganholme, Australia, the company focuses on enhancing personal safety and emergency response through innovative wearable technology.
Vaxxas is a biotechnology company based in Brisbane, Australia, that specializes in developing a needle-free vaccination technology aimed at transforming vaccine delivery. The company's innovative system employs an array of vaccine-coated micro projections that penetrate the outer layers of the skin when applied with a specialized applicator device. This approach allows for direct deposition of vaccines among a dense concentration of immune cells in the skin. Additionally, Vaxxas utilizes proprietary dry-coating technology to minimize or eliminate the need for refrigeration during the storage and transport of vaccines, thereby alleviating the logistical challenges associated with maintaining the cold chain. Founded in 2011, Vaxxas aims to enhance global vaccination efforts through its novel delivery system.
Hatchtech
Venture Round in 2013
Hatchtech is an Australian company focused on developing innovative pest control solutions through its proprietary technology platform. The company's patented approach targets the egg hatch of pest species, effectively disrupting their lifecycle with a novel mode of action. Hatchtech's technology is designed to address various invertebrate pests, including ectoparasites such as head lice, as well as pests affecting animals, crops, and the built environment. Their flagship product offers a single-dose treatment that eliminates both head lice and their eggs in one application, providing an effective solution for infestations.
Hatchtech
Venture Round in 2012
Hatchtech is an Australian company focused on developing innovative pest control solutions through its proprietary technology platform. The company's patented approach targets the egg hatch of pest species, effectively disrupting their lifecycle with a novel mode of action. Hatchtech's technology is designed to address various invertebrate pests, including ectoparasites such as head lice, as well as pests affecting animals, crops, and the built environment. Their flagship product offers a single-dose treatment that eliminates both head lice and their eggs in one application, providing an effective solution for infestations.
Vaxxas is a biotechnology company based in Brisbane, Australia, that specializes in developing a needle-free vaccination technology aimed at transforming vaccine delivery. The company's innovative system employs an array of vaccine-coated micro projections that penetrate the outer layers of the skin when applied with a specialized applicator device. This approach allows for direct deposition of vaccines among a dense concentration of immune cells in the skin. Additionally, Vaxxas utilizes proprietary dry-coating technology to minimize or eliminate the need for refrigeration during the storage and transport of vaccines, thereby alleviating the logistical challenges associated with maintaining the cold chain. Founded in 2011, Vaxxas aims to enhance global vaccination efforts through its novel delivery system.
Smart Sparrow
Series A in 2011
Smart Sparrow operates an innovative e-learning platform that allows educators and organizations to create interactive and adaptive courseware across various subjects, such as digital literacy, computer science, engineering, finance, and soft skills. Founded in December 2010 by Ariel Shoham, Dror Ben-Haim, Shaowei Ho, and Zack Belinson, the company is headquartered in Surry Hills, Australia, with an additional office in San Francisco, California. The platform features a user-friendly, drag-and-drop authoring tool accessible through any web browser, enabling educators to build customized courses, define personalized learning paths for students, and collaborate in real-time. Additionally, Smart Sparrow provides pre-made templates to streamline the course creation process, serving a diverse range of institutions both locally and internationally.
Hatchtech
Venture Round in 2010
Hatchtech is an Australian company focused on developing innovative pest control solutions through its proprietary technology platform. The company's patented approach targets the egg hatch of pest species, effectively disrupting their lifecycle with a novel mode of action. Hatchtech's technology is designed to address various invertebrate pests, including ectoparasites such as head lice, as well as pests affecting animals, crops, and the built environment. Their flagship product offers a single-dose treatment that eliminates both head lice and their eggs in one application, providing an effective solution for infestations.